<DOC>
	<DOC>NCT01099267</DOC>
	<brief_summary>Multi-center, survival data collection in subjects previously enrolled in study NCT00065156 (Celgene Protocol CC-5013-MDS-003).</brief_summary>
	<brief_title>Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003</brief_title>
	<detailed_description />
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<criteria>1. Must have been enrolled in the Celgene protocol CC5013MDS003 study. 2. Must understand and be able to give informed consent (if a subject is deceased, proper legal consent (i.e. next of kin, legal representative) will be obtained prior to collection of data). 1. Consent refused for any reason at current or longterm follow up completed in 2007 (longterm follow up: survival data collection completed to obtain further safety information on CC5013MDS003 discontinued subjects from May October 2007).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>MDS</keyword>
</DOC>